
The Associated Press @AP
Pfizer’s drug has been found to cut the risk of hospitalization or death in people at risk of severe COVID-19 by up to 90%. It is thought to also be effective against omicron, because it does not target the virus’s spike protein, where most mutations are. https://t.co/4l7Bgpk9dg — PolitiTweet.org